Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (5): 28-34.doi: 10.6040/j.issn.1671-7554.0.2024.0186

• Precision medicine in chronic airway diseases—Expert Overview • Previous Articles    

Neuropsychological asthma

WANG Ting1,2,3, ZHANG Li4, WANG Gang1,2,3   

  1. 1. Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, China;
    2. State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, China;
    3. Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, Sichuan University, Chengdu 610041, Sichuan, China;
    4. Division of Internal Medicine, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, China
  • Published:2024-05-29

PDF (PC)

36

Abstract: Bronchial asthma(asthma)is a heterogeneous disease characterized by chronic airway inflammation. Application of multidimensional assessment to identify treatable traits in asthma is expected to improve asthma control and achieve clinical remission. Neuropsychological dysfunction, including anxiety and depression, is important component of the assessment of extrapulmonary treatable traits in asthma. Comorbid anxiety and/or depression can worsen asthma symptoms, reduce quality of life, and increase acute exacerbations, and thus neuropsychological asthma has gained attention as a specific asthma phenotype. This article reviews the epidemiology, clinical consequences, underlying mechanisms, screening tools, and treatments of neuropsychological asthma, in order to provide some information for future research and management of neuropsychological asthma.

Key words: Bronchial asthma, Anxiety, Depression, Neuropsychological dysfunction

CLC Number: 

  • R562.25
[1] GBD Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258): 1204-1222.
[2] Huang KW, Yang T, Xu JY, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study[J]. Lancet, 2019, 394(10196): 407-418.
[3] Menzies-Gow A, Bafadhel M, Busse WW, et al. An expert consensus framework for asthma remission as a treatment goal[J]. J Allergy Clin Immunol, 2020, 145(3): 757-765.
[4] McDonald VM, Hiles SA, Godbout K, et al. Treatable traits can be identified in a severe asthma registry and predict future exacerbations[J]. Respirology, 2019, 24(1): 37-47.
[5] Wu WW, Zhang X, Li M, et al. Treatable traits in elderly asthmatics from the Australasian severe asthma network: a prospective cohort study[J]. J Allergy Clin Immunol Pract, 2021, 9(7): 2770-2782.
[6] Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma[J]. Eur Respir J, 2014, 43(2): 343-373.
[7] Wang G, McDonald VM, Gibson PG. Management of severe asthma: from stepwise approach to therapy to treatable traits?[J]. Precis Clin Med, 2021, 4(4): 293-296.
[8] Wang G, McDonald VM. Contemporary concise review 2020: asthma[J]. Respirology, 2021, 26(8): 804-811.
[9] Wu WW, Zhang X, Li M, et al. Treatable traits in elderly asthmatics from the Australasian severe asthma network: a prospective cohort study[J]. J Allergy Clin Immunol Pract, 2021, 9(7): 2770-2782.
[10] Zhang Q, Wu WW, Li L, et al. Workup of difficult-to-treat asthma: implications from treatable traits[J]. Precis Clin Med, 2023, 6(1): pbad003. doi:10.1093/pcmedi/pbad003.
[11] Zhang L, Zhang X, Zheng J, et al. Depressive symptom-associated IL-1β and TNF-α release correlates with impaired bronchodilator response and neutrophilic airway inflammation in asthma[J]. Clin Exp Allergy, 2019, 49(6): 770-780.
[12] Scott KM, von Korff M, Ormel J, et al. Mental disorders among adults with asthma: results from the World Mental Health Survey[J]. Gen Hosp Psychiatry, 2007, 29(2): 123-133.
[13] Shaw DE, Sousa AR, Fowler SJ, et al. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort[J]. Eur Respir J, 2015, 46(5): 1308-1321.
[14] Hou RH, Ye G, Cheng XJ, et al. The role of inflammation in anxiety and depression in the European U-BIOPRED asthma cohorts[J]. Brain Behav Immun, 2023, 111: 249-258. doi:10.1016/j.bbi.2023.04.011.
[15] Luyster FS, Strollo PJ Jr, Holguin F, et al. Association between insomnia and asthma burden in the severe asthma research program(SARP)III[J]. Chest, 2016, 150(6): 1242-1250.
[16] van de Loo KF, van Gelder MM, Roukema J, et al. Prenatal maternal psychological stress and childhood asthma and wheezing: a meta-analysis[J]. Eur Respir J, 2016, 47(1): 133-146.
[17] Lavoie KL, Bacon SL, Barone S, et al. What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both?[J]. Chest, 2006, 130(4): 1039-1047.
[18] Lavoie KL, Cartier A, Labrecque M, et al. Are psychiatric disorders associated with worse asthma control and quality of life in asthma patients?[J]. Respir Med, 2005, 99(10): 1249-1257.
[19] Li HL, He XL, Liang BM, et al. Anxiety but not depression symptoms are associated with greater perceived dyspnea in asthma during bronchoconstriction[J]. Allergy Asthma Proc, 2015, 36(6): 447-457.
[20] Wang L, Liang R, Zhou T, et al. Identification and validation of asthma phenotypes in Chinese population using cluster analysis[J]. Ann Allergy Asthma Immunol, 2017, 119(4): 324-332.
[21] Zhang L, Zhang X, Zheng J, et al. Co-morbid psychological dysfunction is associated with a higher risk of asthma exacerbations: a systematic review and meta-analysis[J]. J Thorac Dis, 2016, 8(6): 1257-1268.
[22] Davis JB. Neurotic illness in the families of children with asthma and wheezy bronchitis: a general practice population study[J]. Psychol Med, 1977, 7(2): 305-310.
[23] Zhu ZZ, Zhu X, Liu CL, et al. Shared genetics of asthma and mental health disorders: a large-scale genome-wide cross-trait analysis[J]. Eur Respir J, 2019, 54(6): 1901507. doi:10.1183/13993003.01507-2019.
[24] Lehto K, Pedersen NL, Almqvist C, et al. Asthma and affective traits in adults: a genetically informative study[J]. Eur Respir J, 2019, 53(5): 1802142. doi:10.1183/13993003.02142-2018.
[25] Carlson SM, Kim J, Khan DA, et al. Hippocampal volume in patients with asthma: results from the Dallas Heart Study[J]. J Asthma, 2017, 54(1): 9-16.
[26] Kroll JL, Ritz T. Asthma, the central nervous system, and neurocognition: current findings, potential mechanisms, and treatment implications[J]. Neurosci Biobehav Rev, 2023, 146: 105063. doi:10.1016/j.neubiorev.2023.105063.
[27] von Leupoldt A, Sommer T, Kegat S, et al. Down-regulation of insular cortex responses to dyspnea and pain in asthma[J]. Am J Respir Crit Care Med, 2009, 180(3): 232-238.
[28] Dill-McFarland KA, Altman MC, Esnault S, et al. Molecular pathways underlying lung-brain axis signaling in asthma: relevance for psychopathology and neuroinflammation[J]. J Allergy Clin Immunol, 2024, 153(1): 111-121.
[29] Zhu M, Liang ZA, Wang T, et al. Th1/Th2/Th17 cells imbalance in patients with asthma with and without psychological symptoms[J]. Allergy Asthma Proc, 2016, 37(2): 148-156.
[30] Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target[J]. Nat Rev Immunol, 2016, 16(1): 22-34.
[31] He LX, Deng K, Wang J, et al. Clinical subtypes of neutrophilic asthma: a cluster analysis from Australasian severe asthma network[J]. J Allergy Clin Immunol Pract, 2024, 12(3): 686-698.e8.
[32] Deng K, Zhang X, Liu Y, et al. Heterogeneity of paucigranulocytic asthma: a prospective cohort study with hierarchical cluster analysis[J]. J Allergy Clin Immunol Pract, 2021, 9(6): 2344-2355.
[33] Khandaker GM, Pearson RM, Zammit S, et al. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study[J]. JAMA Psychiatry, 2014, 71(10): 1121-1128.
[34] Iwata M, Ota KT, Duman RS. The inflammasome: pathways linking psychological stress, depression, and systemic illnesses[J]. Brain Behav Immun, 2013, 31: 105-114. doi:10.1016/j.bbi.2012.12.008.
[35] Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review[J]. J Psychosom Res, 2002, 52(2): 69-77.
[36] Brown ES, Sayed N, van Enkevort E, et al. A randomized, double-blind, placebo-controlled trial of escitalopram in patients with asthma and major depressive disorder[J]. J Allergy Clin Immunol Pract, 2018, 6(5): 1604-1612.
[37] Brown ES, Howard C, Khan DA, et al. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study[J]. Psychosomatics, 2012, 53(1): 75-80.
[38] Brown ES, Vigil L, Khan DA, et al. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study[J]. Biol Psychiatry, 2005, 58(11): 865-870.
[39] Nagayasu K, Kitaichi M, Nishitani N, et al. Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release[J]. Int J Neuropsychopharmacol, 2013, 16(10): 2295-2306.
[40] Mendez-Enriquez E, Alvarado-Vazquez PA, Abma W, et al. Mast cell-derived serotonin enhances methacholine-induced airway hyperresponsiveness in house dust mite-induced experimental asthma[J]. Allergy, 2021, 76(7): 2057-2069.
[41] Yorke J, Fleming SL, Shuldham CM. Psychological interventions for adults with asthma[J]. Cochrane Database Syst Rev, 2006, 2006(1): CD002982. doi:10.1002/14651858.CD002982.pub3.
[42] Sharrad KJ, Sanwo O, Cuevas-Asturias S, et al. Psychological interventions for asthma in children and adolescents[J]. Cochrane Database Syst Rev, 2024, 1(1): CD013420. doi:10.1002/14651858.CD013420.pub2.
[43] Meuret AE, Rosenfield D, Millard MM, et al. Biofeedback training to increase P CO2 in asthma with elevated anxiety: a one-stop treatment of both conditions?[J]. Psychosom Med, 2023, 85(5): 440-448.
[44] Gephine S, Fry S, Margoline E, et al. Home-based pulmonary rehabilitation for adults with severe asthma exposed to psychosocial chronic stressors[J]. Respir Med, 2023, 217: 107349. doi:10.1016/j.rmed.2023.107349.
[45] McDonald VM, Hamada Y, Agusti A, et al. Treatable traits in asthma: the importance of extrapulmonary traits-GERD, CRSwNP, atopic dermatitis, and depression/anxiety[J]. J Allergy Clin Immunol Pract, 2024, 12(4): 824-837.
[46] Thomas D, McDonald VM, Stevens S, et al. Biologics(mepolizumab and omalizumab)induced remission in severe asthma patients[J]. Allergy, 2024, 79(2): 384-392.
[47] Masefield S, Edwards J, Hansen K, et al. The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership(EARIP)[J]. Eur Respir J, 2017, 49(5): 1602295. doi:10.1183/13993003.02295-2016.
[1] DING Yiren, LIU Wanying, YAO Lei, YAO Xin. Research progress of the treatment of asthma with macrolide antibiotics [J]. Journal of Shandong University (Health Sciences), 2024, 62(5): 21-27.
[2] ZHANG Hengzhe, HOU Xiaohui, Arezou Bikdeli, LI Daqing. Factors influencing the degrees of fatigue after complete revascularization interventions in 152 patients with nonacute myocardial infarction [J]. Journal of Shandong University (Health Sciences), 2023, 61(7): 47-54.
[3] HAN Mei, MENG Weijing, TAO Zikun, YANG Xi, XU Yaqi, MU Huaxia, BU Weixiao, WANG Suzhen, SHI Fuyan. Causal mediation analysis with multiple-mediator of hypertension and depression between type 2 diabetes mellitus and cognitive function based on G-computation [J]. Journal of Shandong University (Health Sciences), 2023, 61(10): 101-108.
[4] ZHAO Hailong, WANG Hao, FANG Yuqing, MAO Fei, ZHAO Zhangning, TIAN Xiangqi, XU Xinrong, WANG Min, LI Xiuhua. Efficacy of additional idebenone in the treatment of 34 patients with Parkinsons disease with depression [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 38-44.
[5] ZHAO Xuan, LI Xiaopeng, LI Jian, TIAN Bin, WANG Guangjun. Therapeutic effects of auricular points sticking with magnetic beads combined with repeated transcranial magnetic stimulation on post-stroke depression [J]. Journal of Shandong University (Health Sciences), 2022, 60(1): 65-70.
[6] FU Wenhao, LI Jiajia, FANG Feng, LI Shixue. Depression status and associated factors among informal caregivers of patients with critical illness [J]. Journal of Shandong University (Health Sciences), 2022, 60(1): 71-77.
[7] SUN Fuyun, WANG Weipeng, ZHANG Huihui, GENG Yan, AN Xiaoxia, LI Shuangshuang, ZHANG Binbin. Correlation among personality traits and depression, anxiety symptoms in patients after colorectal cancer resection [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 91-96.
[8] LIU Jing, YUAN Zhongshang, LI Xiujun, SUN Xiubin, MA Xufei, ZHAO Xiulan. Comprehensive teaching reform and exploration of Medical Statistics under the guidance of “student-centered” concept [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 119-124.
[9] LIU Ping, SONG Yuwen, WANG Ping, TIAN Guangwei, ZHENG Fengjie, LYU Li, DU Jiaojiao, ZHANG Jing, ZHUANG Xianghua, CHEN Shihong. Correlation between vitamin D deficiency and depression in patients with type 2 diabetes mellitus [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 51-56.
[10] SHI Fei, PAN Xiang, YANG Jianming. Analysis of life quality in 106 papillary thyroid carcinoma patients undergoing total thyroidectomy [J]. Journal of Shandong University (Health Sciences), 2020, 58(5): 87-92.
[11] YANG Liping, MU Tingting, YANG Yujuan, ZHANG Yu, SONG Xicheng. Effects of inhaled allergens on pulmonary function in children with adenoid hypertrophy complicated with bronchial asthma [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 107-112.
[12] WANG Wei, YANG Yongqin, MI Guolin. Comparison of the efficacy of escitalopram alone and with Qi Yang Yu Xin Dan Fang in the treatment of female depression with sexual dysfunction [J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 97-101.
[13] CHI Yanna, LIU Xiyao, JU Yanli, YIN Zhouyi, Bob Lew, JIA Cunxian. Reliability and validity of the Anxiety Depression Distress Inventory-27 among medical college students [J]. Journal of Shandong University (Health Sciences), 2019, 57(9): 114-118.
[14] SUN Yaoyao, LIU Fei, CAO Fenglin. Job burnout subtypes and emotional problems among medical staff in a tertiary hospital [J]. Journal of Shandong University (Health Sciences), 2019, 57(6): 100-105.
[15] ZHAO Ketong, ZHAO Jing, Aiyelabowo Faith, WANG Ying. Effects of implanted cardiac permanent pacemaker on anxiety or depression associated with bradyarrhythmia [J]. Journal of Shandong University (Health Sciences), 2018, 56(7): 39-45.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd